Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of
the COVID-19 global pandemic. SARS-CoV-2 is an enveloped RNA virus that relies on its …

Operation Nasal Vaccine—Lightning speed to counter COVID-19 | Science Immunology news
careers commentary Journals Science Science brought to you byGoogle Indexer Log in science …

Background The live-attenuated influenza virus vector-based intranasal SARS-CoV-2
vaccine (dNS1-RBD, Pneucolin; Beijing Wantai Biological Pharmacy Enterprise, Beijing …

SARS-CoV-2 variants that attenuate antibody neutralization could jeopardize vaccine
efficacy. We recently reported the protective activity of an intranasally administered spike …

Remarkable progress has been made in developing intramuscular vaccines against severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2); however, they are limited with …

To develop a vaccine candidate against coronavirus disease 2019 (COVID-19), we
generated a lentiviral vector (LV) eliciting neutralizing antibodies against the Spike …

The sudden emergence of a highly transmissible and pathogenic coronavirus SARS-CoV-2
in December 2019 from China and its rapid global spread has posed an international health …

The outbreak of coronavirus disease 2019 (COVID-19) has posed great threats to global
health and economy. Several effective vaccines are available now, but additional booster …

The coronavirus disease 2019 pandemic has made deployment of an effective vaccine a
global health priority. We evaluated the protective activity of a chimpanzee adenovirus …

The highly contagious SARS-CoV-2 Omicron subvariants severely attenuated the
effectiveness of currently licensed SARS-CoV-2 vaccines based on ancestral strains …